|
Insider Trading: BIOMIMETIC THERAPEUTICS, INC.
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of BIOMIMETIC THERAPEUTICS, INC. in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of BIOMIMETIC THERAPEUTICS, INC. since year 2005. Table 2 shows the detailed insider transactions of BIOMIMETIC THERAPEUTICS, INC. since 2005.
The reporting company's ticker symbol is BMTI.
The reporting company's CIK number is 1138400.
The total value of stock buying since 2005 is $17,520,149.
The total value of stock sales is $4,289,077.
The total value of stock exercises is $703,495.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at BIOMIMETIC THERAPEUTICS, INC. (BMTI) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at BIOMIMETIC THERAPEUTICS, INC. (BMTI) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for BIOMIMETIC THERAPEUTICS, INC. (BMTI).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-07 | 5,146 | 56,606 | 0 | 0 | 0 | 0 |
| 2008-06 | 248,202 | 2,730,222 | 0 | 0 | 0 | 0 |
| 2008-05 | 224,273 | 2,348,849 | 0 | 0 | 0 | 0 |
| 2008-04 | 344,285 | 3,407,546 | 0 | 0 | 8,500 | 30,855 |
| 2008-03 | 30,975 | 275,664 | 0 | 0 | 103,250 | 315,993 |
| 2008-01 | 3,500 | 53,331 | 0 | 0 | 0 | 0 |
| 2007-12 | 0 | 0 | 14,000 | 237,579 | 0 | 0 |
| 2007-09 | 6,500 | 97,013 | 0 | 0 | 0 | 0 |
| 2007-08 | 0 | 0 | 0 | 0 | 24,000 | 31,920 |
| 2007-06 | 0 | 0 | 0 | 0 | 108,750 | 324,727 |
| 2007-02 | 0 | 0 | 236,239 | 4,051,498 | 0 | 0 |
| 2007-01 | 671,150 | 8,360,918 | 0 | 0 | 0 | 0 |
| 2006-05 | 23,750 | 190,000 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for BIOMIMETIC THERAPEUTICS, INC. (BMTI)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-07-07 | Novo A/s (10% Owner) | Purchase | 5,146 | 11.00 | 56,606 |
| 2008-06-24 | Novo A/s (10% Owner) | Purchase | 248,202 | 11.00 | 2,730,222 |
| 2008-05-22 | Novo A/s (10% Owner) | Purchase | 12,931 | 10.95 | 141,597 |
| 2008-05-13 | Novo A/s (10% Owner) | Purchase | 7,843 | 10.96 | 85,933 |
| 2008-05-09 | Novo A/s (10% Owner) | Purchase | 25,100 | 10.87 | 272,940 |
| 2008-05-08 | Novo A/s (10% Owner) | Purchase | 30,739 | 10.39 | 319,173 |
| 2008-05-07 | Novo A/s (10% Owner) | Purchase | 21,561 | 10.39 | 223,236 |
| 2008-05-06 | Novo A/s (10% Owner) | Purchase | 34,100 | 10.28 | 347,404 |
| 2008-05-05 | Novo A/s (10% Owner) | Purchase | 39,182 | 10.63 | 416,397 |
| 2008-05-02 | Novo A/s (10% Owner) | Purchase | 700 | 10.50 | 7,350 |
| 2008-04-29 | Novo A/s (10% Owner) | Purchase | 253,693 | 9.88 | 2,506,296 |
| 2008-04-28 | Novo A/s (10% Owner) | Purchase | 44,200 | 10.02 | 439,830 |
| 2008-04-25 | Novo A/s (10% Owner) | Purchase | 11,392 | 10.08 | 114,786 |
| 2008-04-14 | Douglas Earl Martin (General Counsel) | Option Exercise | 8,500 | 3.63 | 30,855 |
| 2008-03-31 | Hart Charles Edward (Chief Scientific Officer &VP) | Option Exercise | 35,000 | 2.87 | 100,450 |
| 2008-03-28 | Friedlaender Gary E (Director) | Purchase | 8,500 | 8.99 | 76,446 |
| 2008-03-28 | Douglas Earl Martin (General Counsel) | Purchase | 1,000 | 9.05 | 9,050 |
| 2008-03-28 | Lynch Samuel Eugene (President and CEO) | Purchase | 5,400 | 8.93 | 48,231 |
| 2008-03-28 | Murphy James G (Director) | Purchase | 5,000 | 8.40 | 42,000 |
| 2008-03-28 | Federico Charles (Director) | Purchase | 1,075 | 9.24 | 9,937 |
| 2008-03-28 | Bullock Lawrence E (Chief Financial Officer) | Purchase | 10,000 | 9.00 | 90,000 |
| 2008-03-27 | Watson Douglas G (Director) | Option Exercise | 21,375 | 2.91 | 62,262 |
| 2008-03-05 | Monsor James A. (VP - Operations) | Option Exercise | 46,875 | 3.27 | 153,281 |
| 2008-01-23 | Douglas Earl Martin (General Counsel) | Purchase | 3,500 | 15.24 | 53,331 |
| 2007-12-31 | Monsor James A. (VP - Operations) | Sale | 14,000 | 16.97 | 237,579 |
| 2007-09-11 | Papasan Larry W (Director) | Purchase | 6,500 | 14.93 | 97,013 |
| 2007-08-30 | Monsor James A. (VP - Operations) | Option Exercise | 24,000 | 1.33 | 31,920 |
| 2007-06-04 | Citron Mark Barry (Other) | Option Exercise | 108,750 | 2.99 | 324,727 |
| 2007-02-14 | Lynch Samuel Eugene (President and CEO) | Sale | 236,239 | 17.15 | 4,051,498 |
| 2007-01-25 | Novo A/s (10% Owner) | Purchase | 335,575 | 12.46 | 4,180,459 |
| 2007-01-25 | Dyrberg Thomas (Director) | Purchase | 335,575 | 12.46 | 4,180,459 |
| 2006-05-15 | Ehrlich Christopher B (Director) | Purchase | 1,250 | 8.00 | 10,000 |
| 2006-05-12 | Lynch Samuel Eugene (President and CEO) | Purchase | 12,500 | 8.00 | 100,000 |
| 2006-05-12 | Bullock Lawrence E (Chief Financial Officer) | Purchase | 10,000 | 8.00 | 80,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of BIOMIMETIC THERAPEUTICS, INC. (symbol BMTI,
CIK number 1138400) see
the Securities and Exchange Commission (SEC) website.
|
|
